IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Commodore Capital LP

Q2 2023 Holdings

Filed 2023-08-14 | 26 holdings | $889.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Merus N VCOMN5749R100$105.3M4,000,00011.8%
Vera Therapeutics Inc(VERA)CL A92337R101$87.5M5,450,0009.8%
Akero Therapeutics Inc(AKRO)COM00973Y108$78.2M1,675,0008.8%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$71.0M1,845,0008.0%
Cogent Biosciences Inc(COGT)COM19240Q201$65.9M5,566,0267.4%
Viridian Therapeutics Inc(VRDN)COM92790C104$52.3M2,200,0005.9%
Ambrx Biopharma IncSPONSORED ADS02290A102$52.3M3,175,0005.9%
Vaxcyte Inc(PCVX)COM92243G108$50.7M1,015,0005.7%
Nuvalent Inc(NUVL)COM670703107$48.5M1,150,0005.4%
Enliven Therapeutics Inc(ELVN)COM29337E102$47.9M2,348,2725.4%
Cabaletta BIO Inc(CABA)COM12674W109$30.6M2,368,1863.4%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$22.2M2,025,0002.5%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$21.8M610,0002.4%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$21.4M631,6652.4%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$20.9M997,5962.3%
Ideaya Biosciences Inc(IDYA)COM45166A102$18.2M775,0002.0%
Immunovant Inc(IMVT)COM45258J102$17.1M900,0001.9%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$15.9M10,000,0001.8%
Celcuity Inc(CELC)COM15102K100$15.9M1,444,1411.8%
Kura Oncology Inc(KURA)COM50127T109$14.8M1,400,0001.7%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$13.6M1,325,0001.5%
DAY One Biopharmaceuticals I(DAWN)COM23954D109$8.8M739,6611.0%
Third Harmonic BIO Inc(THRD)COM88427A107$4.8M993,2940.5%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$2.8M312,5530.3%
Aeglea Biotherapeutics Inc(AGLEUSD)COM00773J103$1.3M2,908,1000.1%
DBV Technologies S ASPONSORED ADR23306J101$176.1K92,6870.0%